Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves
bodnarchuk/iStock through Getty Photos Paulson & Co. exited its place in AngloGold Ashanti (NYSE:AU) in Q3, in accordance with the fund’s newest 13F submitting. The fund elevated its stake in Madrigal Prescribed drugs. Paulson & Co. additionally decreased its place in Altice USA (ATUS) in